Feed/Investors/SV Life Sciences

SV Life Sciences

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2016-09-21

ROUNDS

as lead investor

LED ROUNDS · USD

$33.2M

across 1 round

LATEST ROUND

Series A · $33.2M · 2016-09-21

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Artios Pharma Artios is a clinical-stage oncology company developing new medicines targeting DNA damage response pathways in cancer for patients with limited treatment options.	Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$33.2M	2016-09-21	[ LEAD ]